Patient harm from ads for Opdivo and other cancer immunotherapies – HealthNewsReview.org
HealthNewsReview.org |
Patient harm from ads for Opdivo and other cancer immunotherapies
HealthNewsReview.org But information about the potential harms of immunotherapy often lags behind, perhaps because that information is not systematically collected in the clinical trials used to support approval of these drugs. In fact, it was only in February 2018, years … |
